n Nigeria Cannabis is associated with a lot of bad bad omen but that is if you are still caught up in outdated facts.
Cannabis in recent years has become more widely accepted and that is due to the numbers of studies telling us of the many good side to the herb.
And one of such good side is its ability due to a certain compound it possesses (cannabis-derived chemical cannabidiol (CBD) ) to help contain the cognitive effects in schizophrenic patients.
The study review on the compound that took place at the University of Wollongong, was conducted by Dr. Katrina Green, Professor Nadia Solowij, and Wollongong PhD candidate Ashleigh Osborne.
According to Dr. Katrina Green:
“From this review, we found that CBD will not improve learning and memory in healthy brains, but may improve aspects of learning and memory in illnesses associated with cognitive impairment, including Alzheimer’s disease, as well as neurological and neuro-inflammatory disorders,”
“We found that CBD was able to restore recognition and working memory, as well as social behavior, to normal levels,” Osborne said in a release. “These findings are interesting because they suggest that CBD may be able to treat some of the symptoms of schizophrenia that are seemingly resistant to existing medications. In addition, CBD treatment did not alter body weight or food intake, which are common side effects of antipsychotic drug treatment.”
Osborne explaining to ABC News Australia, “This is really important because current antipsychotic drugs don’t address the cognitive deficits, which approximately 80% of patients with schizophrenia experience.”
“This is the first study to prove Cannabidiol can be used to treat symptoms of schizophrenia that aren’t addressed by current medications,” Osborne told ABC News. “These findings are really promising but further research is needed to see if these findings translate to people suffering from schizophrenia.”
She added, “Ultimately, we hope that these findings lead to new improved medications.